Sjöberg P, Egestad B, Klasson-Wehler E, Gustafsson J
Medical Products Agency, Uppsala, Sweden.
Biochem Pharmacol. 1991 May 15;41(10):1493-6. doi: 10.1016/0006-2952(91)90566-n.
A method for assaying mono(2-ethylhexyl)phthalate (MEHP) uridine diphosphate (UDP) glucuronyl transferase activity in microsomal preparations from guinea pig liver is described. The quantitation of the MEHP-glucuronide was performed by HPLC after direct injection of a sample of deproteinized incubation mixture. Solubilization of microsomal UDP-glucuronyltransferase activity was achieved by use of Lubrol, and optimal conditions for glucuronidation of MEHP were established. To investigate whether there is competition between MEHP and bilirubin for glucuronidation, inhibition experiments were performed with solubilized enzyme preparations. In these incubations addition of bilirubin decreased the formation of MEHP-glucuronide. No change in the maximal conversion rate (Vmax) was observed, indicating the occurrence of competitive inhibition. This observation may have implications in clinical situations where patients with hyperbilirubinemia are exposed to MEHP, e.g. in exchange transfusions in newborn infants.
本文描述了一种用于测定豚鼠肝脏微粒体制剂中单(2-乙基己基)邻苯二甲酸酯(MEHP)尿苷二磷酸(UDP)葡萄糖醛酸转移酶活性的方法。在直接注射脱蛋白孵育混合物样品后,通过高效液相色谱法(HPLC)对MEHP-葡萄糖醛酸化物进行定量。通过使用Lubrol实现微粒体UDP-葡萄糖醛酸转移酶活性的增溶,并确定了MEHP葡萄糖醛酸化的最佳条件。为了研究MEHP和胆红素在葡萄糖醛酸化过程中是否存在竞争,对增溶的酶制剂进行了抑制实验。在这些孵育实验中,加入胆红素会减少MEHP-葡萄糖醛酸化物的形成。未观察到最大转化率(Vmax)的变化,表明发生了竞争性抑制。这一观察结果可能对高胆红素血症患者接触MEHP的临床情况有影响,例如新生儿换血治疗。